3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Breast
1
Conditions
Breast Neoplasms
68
Neoplasms
32
Prostatic Neoplasms
30
Lung Neoplasms
24
Head and Neck Neoplasms
20
Neoplasm Metastasis
15
Motor Activity
14
Colorectal Neoplasms
14
Multiple Myeloma
13
Ovarian Neoplasms
11
Gastrointestinal Neoplasms
11
Fatigue
10
Carcinoma, Non-Small-Cell Lung
10
cyclopia sequence
8
Uterine Cervical Neoplasms
8
Pancreatic Neoplasms
8
Pain
8
Lymphoma
8
Anxiety Disorders
8
Smoking Cessation
7
Recurrence
7
Neoplasms, Plasma Cell
7
Esophageal Neoplasms
7
Endometrial Neoplasms
7
Carcinoma, Renal Cell
7
Tobacco Use Cessation
6
Rectal Neoplasms
6
Oropharyngeal Neoplasms
6
Leukemia
6
Depression
6
Interventions
posaconazole
1
liposomal doxorubicin
1
Vinorelbine
1
Surveys and Questionnaires
1
Prophylactic Mastectomy
1
Multiparametric Magnetic Resonance Imaging
1
Minoxidil
1
High-Throughput Nucleotide Sequencing
1
Fluconazole
1
Exome
1
Docetaxel
1
Cephalexin
1
Capecitabine
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Genetic Predisposition to Disease
×
Surveys and Questionnaires
×
Clear all
NCT04145817
2025-11-24
BRIDGEScohort2
Institut Curie
Phase NA
Completed
405 enrolled